RUNX1 Early Career Investigator Grant: Up to $180,000 over three years
The purpose of the RUNX1 Early Career Investigator Grant is to promote the establishment of a new generation of translational and clinical researchers interested in tackling inherited hematologic malignancy predisposition disorders with a focus on RUNX1-familial platelet disorder. We believe that providing capital to early career investigators not only injects funding into where it is needed most, but also cultivates a new cohort of investigators who will be invested in an area of research that historically has had limited attention. The Program is viewed as a long-term endeavor of collaboration and data sharing. We are especially interested in innovative and cross-disciplinary approaches to developing effective therapies.
The RUNX1 Early Career Investigator Grant is currently being offered. To apply, please visit the Applicant page.
Familial RUNX1 Grant:
The purpose of the Familial RUNX1 grant is to fund research in strategies leading to the development of therapies to prevent the transition from pre-leukemia to leukemia for patients with FPD/AML. Projects focus on leukemia caused by familial RUNX1 mutations rather than sporadic AML with somatic RUNX1 mutations.